INCY
NASD Incyte Corporation$124.82 ↑ +0.00 (+0.00%) Trading Up from the previous close of $124.82, $1.32 below the day’s high of $126.14
- YTD change
- +26.37%
- vs 20-day SMA
- -0.04%
- vs 200-day SMA
- +17.48%
Price ranges
Price & Performance
+34.49 (+38.18%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 18.5% away from all-time highs of $153.15
- INCY is up 26% since the beginning of the year
- INCY is up 51% over the past 12 months
- INCY is down 2% over the past 1 month
- 5% of all INCY investors are betting against INCY
INCY reads very good: price sits above one of the two key moving averages, the 12-month move is +48.8%.
- Previous minute
- +$0.00
- Last hour
- +$0.00
- Last 5 days
- -0.39%
- vs 8-day SMA
- -0.37%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas. The company was founded on April 8, 1991 and is headquartered in Wilmington, DE.
Competitor comparison
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.